Amivantamab (Anti-cMet & EGFR)
£288.00
Amivantamab (Anti-cMet & EGFR) (A4000-1mg)
Product
| Cat # A4000-1mg | Size 1mg |
Price
£288.00
|
Qty
|
Description
Amivantamab is a fully human bispecific antibody that targets both epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET). It exhibits immune anticancer activity in non-small cell lung cancer (NSCLC). MW :145.88 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Product Size | 1mg |
| Manufacturer Cat# | A4000 |
| Target | EGFR |